The U.S. House of Representatives passed U.S. Senator Marco Rubio’s (R-FL) Pensacola and Perdido Bays Estuary of National Significance Act (S. 50) to direct the Environmental Protection Agency to formally enroll the Pensacola and Perdido Bays Estuary Program (PPBEP)...
U.S. Senator Marco Rubio (R-FL) released a statement on his nomination by President-elect Donald J. Trump to serve as the United States Secretary of State. “Leading the U.S. Department of State is a tremendous responsibility, and I am honored by the trust President...
U.S. Senator Marco Rubio (R-FL) joined The World Over with Raymond Arroyo to discuss President-elect Donald Trump’s historic victory, the Democrats’ response to the election, foreign policy challenges facing our nation, and more. See below for highlights and watch the...
U.S. Senator Marco Rubio (R-FL) joined America Reports to discuss President-elect Donald Trump’s historic victory, Democrats’ proclamation of “resistance,” and the failure of identity politics. See below for highlights and watch the full interview on YouTube and...
Senator Rubio's office is pleased to be issuing a limited number of tickets to President-elect Donald Trump's inauguration ceremony, which will occur on January 20, 2025 at the West Front of the U.S. Capitol. Floridians interested in receiving tickets should fill out...
U.S. Senator Marco Rubio (R-FL) joined Hannity to discuss President-elect Donald Trump’s historic victory. See below for highlights and watch the full interview on YouTube and Rumble. On the ongoing realignment among American voters: “The Republican Party now reflects...
Washington, D.C. — U.S. Senators Marco Rubio (R-FL) and Chris Coons (D-DE) introduced the Agility in Manufacturing Preparedness Act (S.3553) to require the U.S. Department of Health and Human Services (HHS) and the Biomedical Advanced Research and Development Authority (BARDA) to contract with the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) for the purpose of evaluating the current capacity and vulnerabilities of biopharmaceutical manufacturing in the United States. NIIMBL is a public-private partnership focused on improving manufacturing capabilities through its cutting-edge expertise, which would help the federal government enhance its preparedness and response capabilities for emerging public health threats. Rubio and Coons first introduced this bill as an amendment (#1917) to the Senate’s Endless Frontier Act in May 2021.
“America needs to be able to make things again, especially medicine,” Rubio said. “My new bill will help bring that back.”
“The current global health crisis has once again underscored the importance of sustained attention to potential threats and our preparedness for them. Expanding our manufacturing capacity in the United States and ensuring that it can respond to a variety of threats is imperative,” Coons said. “The Agility in Manufacturing Preparedness Act will put us in a position to improve our medical preparedness and support America’s health.”
The legislation specifically requires NIIMBL, in partnership with HHS, to: